Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Virginia Beach › NPI 1316464837
Lab

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings was paid $61K by Medicaid between Jun 2020 and Jun 2024, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 88% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
VIRGINIA BEACH, VA 23454
33aNPI1316464837assigned 08/25/2017
28Total paid$61K
24GClaims1,947
24DCodes billed4
24AFirst – last monthJun 2020 – Jun 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#37 of 78
Median peer was paid$37K
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202065$1K
20211,543$55K
2022286$5K
202338$2.55
2024incomplete15$9.51
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 88% 1,100 872 $54K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 12% 412 359 $7K
81001 <1% 423 367 $47.69
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 0% 12 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.